Table 1.
Specimen ID # | Source | Methylation | SB-LGE | SB-PFGE | OGM | Shipping/Storing | Molecules ≥ 150 Kbp | N50 > 0.2 | Map Rate (%) | Effective Coverage | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4q_1 | Outcome | 4q_1 | 4q_2 | Outcome | 4q_1 | 4q_2 | Outcome | ||||||||||||
FseI (delta1) * | U | U | A/B | U | A/B | U | A/B | U | A/B | ||||||||||
NHNN_FSH001 | UK | NA | >10 | No F1 No F2 | 23 | B | 24 | B | Negative | 23 | B | 24 | B | No F1, No F2 | d1, −80 °C | 332 | 0.277 | 94 | 166× |
NHNN_FSH002 | UK | NA | 7 | FSHD1 | NA | NA | NA | NA | - | 7 | A | 49 | A | FSHD1 | d1, −80 °C | 304 | 0.248 | 95 | 151× |
NHNN_FSH003 | UK | NA | 6 | FSHD1 | NA | NA | NA | NA | - | 6 | A | 39 | A | FSHD1 | d1, −80 °C | 382 | 0.340 | 93 | 147× |
NHNN_FSH004 | UK | NA | 8 | FSHD1 | NA | NA | NA | NA | - | 7 | A | 29 | A | FSHD1 | d1, −80 °C | 242 | 0.186 | 91 | 142× |
NHNN_FSH005 | UK | NA | >10 | FSHD2 | NA | NA | NA | NA | - | 18 | A | 24 | B | FSHD2 | d1, −80 °C | 293 | 0.228 | 65 | 106× |
NHNN_FSH006 | UK | NA | 1 | FSHD1 # | NA | NA | NA | NA | - | [1(64%);43(36%)] | A | 26 | B | FSHD1 mosaic | d1, −80 °C | 258 | 0.198 | 91 | 172× |
NHNN_FSH007 | UK | NA | 5 | FSHD1 | NA | NA | NA | NA | - | 5 | A | 27 | B | FSHD1 | d1, −80 °C | 220 | 0.158 | 88 | 145× |
NHNN_FSH008 | UK | −13 | 11 | No F1, No F2 | 10 | A | 10 | A | FSHD1 ^ | 10 | A | 10 | A | FSHD1 ^ | d1, −80 °C | 213 | 0.143 | 79 | 122× |
NHNN_FSH009 | UK | NA | 8 | FSHD1 | NA | NA | NA | NA | - | 7 | A | 18 | A | FSHD1 | d1, −80 °C | 203 | 0.120 | 75 | 83× |
NHNN_FSH010 | UK | NA | >10 | No F1, No F2 | 13 + 6 | A | 22 | A | FSHD dup | 13 + D | A | 22 | A | FSHD dup | d1, −80 °C | 203 | 0.142 | 83 | 131× |
IC_AIM_000950 | India | 0 | NA | - | 12 | B | 43 | A | No F1, No F2 | 12 | B | 42 | A | No F1, No F2 | 4 °C, d7, −80 °C | 251 | 0.131 | 80 | 134× |
IC_AIM_000918 | India | NA | NA | - | 2 | A | 23 | B | FSHD1 | 2 | A | 23 | B | FSHD1 | 4 °C, d7, −80 °C | 237 | 0.126 | 81 | 136× |
IC_AIM_000955 | India | NA | NA | - | 5 | A | 22 | A | FSHD1 | 4 | A | 22 | A | FSHD1 | 4 °C, d7, −80 °C | 228 | 0.118 | 74 | 105× |
IC_AIM_000957 | India | NA | NA | - | 5 | A | 39 | A | FSHD1 | 4 | A | 38 | A | FSHD1 | 4 °C, d7, −80 °C | 249 | 0.103 | 77 | 123× |
IC_AIM_000904 | India | NA | NA | - | 3 | A | 24 | B | FSHD1 | 3 | A | 24 | B | FSHD1 | 4 °C, d7, −80 °C | 220 | 0.094 | 67 | 107× |
IC_AIM_000963 | India | NA | NA | - | 4 | A | 25 | A | FSHD1 | 4 | A | 25 | A | FSHD1 | 4 °C, d7, −80 °C | 270 | 0.158 | 83 | 132× |
IC_AIM_000932 | India | −35 | NA | - | 9 | A | 12 | B | FSHD2 | 9 | A | 12 | B | FSHD2 | 4 °C, d7, −80 °C | 236 | 0.105 | 80 | 122× |
IC_AIM_001042 | India | −41 | NA | - | 19 | A | 19 | A | FSHD2 | 20 | A | 20 | A | FSHD2 | 4 °C, d7, −80 °C | 221 | 0.090 | 38 | 62× |
IC_AIM_001045 | India | NA | NA | - | 5 | A | 25 | B | FSHD1 | 4 | A | 25 | B | FSHD1 | 4 °C, d7, −80 °C | 213 | 0.100 | 64 | 112× |
IC_AIM_001053 | India | NA | NA | - | 4 | A | 21 | B | FSHD1 | 3 | A | 21 | B | FSHD1 | 4 °C, d7, −80 °C | 235 | 0.147 | 78 | 123× |
IC_AIM_001055 | India | NA | NA | - | 6 | A | 25 | A | FSHD1 | 7 | A | >11 | ND | FSHD1 | 4 °C, d7, −80 °C | 185 | 0.083 | 42 | 66× |
IC_AIM_000820 | India | NA | NA | - | 4 | A | 23 + 6 | AD | FSHD1 | 3 | A | 24 + D | A | FSHD1 | 4 °C, d5 | 212 | 0.161 | 78 | 51× |
IC_AIM_00152 | India | 16 | NA | - | 28 | A | 59 + 3 | AD | FSHD dup | 26 | A | 61 + D | A | FSHD dup | 4 °C, d5 | 289 | 0.234 | 88 | 102× |
IC_AIM_000701 | India | NA | NA | - | [2(40%);20(60%)] | A | 10 | B | FSHD1 mosaic | [2(36%);21(64%)] | A | 10 | B | FSHD1 mosaic | 4 °C, d5 | 260 | 0.177 | 80 | 128× |
IC_AIM_000531 | India | −8 | NA | - | 17 | B | 20 | A | No F1, No F2 | 17 | B | 21 | A | No F1, No F2 | 4 °C, d5 | 250 | 0.167 | 74 | 89× |
* delta1 values represent repeat size-corrected D4Z4 methylation calculated as described in Lemmers et al. 2014 [17]. # mosaicism character of the FSHD1 allele was not identified by SB-LGE in sample NHNN_FSH006. ^ homozygous 10 U. NHNN_FSHD008 has a phenotype consistent with FSHD (facial weakness; shoulder and pelvic girdle weakness) and was found to contain Homozygous 10 U via OGM.